Last reviewed · How we verify

NCT06362824

Promoting Physical Activity in Older Hispanic/Latino(a) Adults

Recruiting now NA Last updated 8 April 2026
What this trial tests

NA trial testing De Pie Intervention in Sedentary Behavior in 130 participants. Currently enrolling.

Timeline
24 September 2024
Primary endpoint
31 December 2026
31 May 2027

Quick facts

Lead sponsorKaiser Permanente
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment130
Start date24 September 2024
Primary completion31 December 2026
Estimated completion31 May 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kaiser Permanente — full company profile →

Who can join

Adults 55 to 89, any sex, with Sedentary Behavior or Physical Inactivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this randomized controlled trial, study staff will randomize 130 Hispanic/Latino adults without dementia and over age 55 from Southern California and from Kaiser Permanente Washington (State) to either the culturally adapted De Pie physical activity intervention or an active comparison program focusing on general brain health topics. The purpose of this study is to determine if 12 weeks of the culturally adapted and fully remote De Pie y a Movernos intervention improves self-efficacy, habit strength, social support, and enjoyment for physical activity (PA), thus promoting adherence to moderate-intensity physical activity (MIPA) guidelines (150 minutes/week).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sedentary Behavior

Currently open trials in the same condition.

Other Kaiser Permanente trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06362824.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing